News story

Product defect recall alert for four products by Dechra Pharmaceuticals PLC

Wholesaler level recall alert for four products by Dechra Pharmaceuticals PLC.

We wish to inform wholesalers that Dechra Pharmaceuticals PLC has initiated a Class II recall to wholesaler level with immediate effect for the following products:

  • Apovomin 3 mg/ml Solution for Injection for Dogs, Vm50406/4002

  • Ophtocycline 10 mg/g eye ointment for dogs, cats and horses, Vm41821/4043

  • Revozyn RTU 400 mg/ml suspension for injection for cattle, Vm16849/3000 & Vm16849/5000

  • Equipalazone 200 mg/ml Solution for Injection Vm50406/3037 & Vm50406/5042

The reason for the recall is due to an increased risk of microbial contamination in the aseptically manufactured products at the site of the contracted manufacturer, in the period from 01/2024 to 05/2025.

This recall is for following batches:

Product Batch number Date of Manufacture Expiry date
Apovomin 3 mg/ml solution for injection for dogs 24K017 Nov 2024 Oct 2027
Apovomin 3 mg/ml solution for injection for dogs 25B254 Feb 2025 Jan 2028
Ophtocycline 10 mg/g eye ointment for dogs, cats and horses EB Jan 2025 Dec 2025
Ophtocycline 10 mg/g eye ointment for dogs, cats and horses ED May 2024 Apr 2026
Ophtocycline 10 mg/g eye ointment for dogs, cats and horses EF May 2024 Apr 2026
Ophtocycline 10 mg/g eye ointment for dogs, cats and horses FA Jan 2025 Dec 2026
Ophtocycline 10 mg/g eye ointment for dogs, cats and horses FC May 2025 Apr 2027
Revozyn RTU 400 mg/ml suspension for injection for cattle 24J014 Oct 2024 Sep 2026
Equipalazone 200 mg/ml Solution for Injection 151300 April 2024 Mar 2027
Equipalazone 200 mg/ml Solution for Injection 152435 April 2024 Mar 2027

Dechra Pharmaceuticals PLC is contacting wholesalers to examine inventory immediately and quarantine products, subject to this recall.

For further information regarding the recall, please contact: quality@dechra.com, or eu.recall@dechra.com

Updates to this page

Published 22 October 2025